Cervical cancer
Conditions
Interventions
Group A:DEB-UACE + concurrent radiotherapy
Sponsors
The Affiliated Cancer Hospital of Guizhou Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 69 Years
Inclusion criteria
Inclusion criteria: 1. Aged >= 18 and = 70, ECOG 3 months; 6. MRI confirmed the mass on the cervix; 7. Patients who are not pregnant and not breastfeeding; 8. The patient receives the treatment plan; 9. The patients agreed to participate in this study and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. The patient has an overt infection; 2. Have serious complications, such as heart disease, poorly controlled diabetes, high blood pressure, bleeding tendency; 3. The patient has taken other anti-tumor drugs within 30 days before the start of the trial; 4. Patients who are receiving other chemotherapy, hormone therapy, immunotherapy or radiation therapy; 5. Currently suffering from other malignant tumors; 6. Patients who are considered inappropriate by other researchers in this program.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to progression;Progress free survival;Vaginal bleeding;The degree of pain;Quality of life score; | — |
Countries
China
Contacts
Public ContactZhao Xuya
The Affiliated Cancer Hospital of Guizhou Medical University
Outcome results
None listed